Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics [Paperback] Author: Amazon Prime Sign in to turn on 1-Click ordering | Language: English | ISBN:
3764383615 | Format: PDF, EPUB
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics Download books file now Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics [Paperback] from 4shared, mediafire, hotfile, and mirror link
This book describes the authors' standard or 'best' practices used in writing regul- ed clinical documents for the drug and biologics industry. The fundamental premise of this book is that the end (documents submitted to a health authority) is dep- dent on the beginning (the planning and strategy that go into organizing written documentation). Each regulatory document inherently exists within a constellation of related documents. This book attempts to show the relationships between and among these documents and suggests strategies for organizing and writing these documents to maximize ef?ciency while developing clear and concise text. At all times, and irrespective of applicable laws and guidelines, good communication skills and a sense of balance are essential to adequately, accurately, and clearly describe a product's characteristics. At no time should the reader perceive these suggestions to be the only viable solution to writing regulatory documents nor should the reader expect that these suggestions guarantee product success. The audience for this book is the novice medical writer, or those who would like to explore or enhance regulatory-writing skills. We assume the reader will have a basic understanding of written communication, but little experience in applying this skill to the task of regulatory writing. Extensive knowledge of science, clinical me- cine, mathematics, or regulatory affairs law is not required to use the best practices described in this book.
Books with free ebook downloads available Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics [Paperback]
- Paperback: 238 pages
- Publisher: Birkhäuser; 2009 edition (November 18, 2008)
- Language: English
- ISBN-10: 3764383615
- ISBN-13: 978-3764383619
- Product Dimensions: 0.6 x 6.1 x 9.1 inches
- Shipping Weight: 15.5 ounces (View shipping rates and policies)
- Amazon Best Sellers Rank: #501,300 in Books (See Top 100 in Books)
While ICH has told the global clinical development community what they want there has been confusion as to how to implement the guidelines. The confusion is particularly acute in the small biotech firms where MDs, PhDs and PharmDs are given the sole authority to write protocols, clinical study reports, integrated summaries of safety and efficacy without the oversight and SOPs that guide these steps in Big Pharma. Wood and Foote have created an outstanding book which should serve as a reference for clinical development professionals worldwide. Through clear narratives and templates they tell the reader how to create all the documents needed in a clinical development program even including this information for Japan which has long been a source of confusion even in Big Pharma.
By Jay Herson
This is a fine reference book. But, it is NOT well served by the Kindle. The tables are almost impossible to read, even with the zoom plus a magnifying glass. (The zoom hardly enlarges the tables and figures at all.) It is also the kind of book that you want to refer to "as needed" for certain types of documents. Navigating to the pages you want to refer to is extremely difficult. Get the paper version for this one!
By C. Strecker
Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics Download
Please Wait...